Experts highlight how adrenal disorders such as Conn’s syndrome and Cushing’s syndrome can silently damage the kidneys.

Endoscopic surgery has become the customary technique for removing small—6 cm or less in diameter—nonmalignant adrenal tumors. It is not clear, however, whether the procedure is also indicated for ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...

'I’ve had to have my heart restarted once, twice, or more' ...

JAMMU, Mar 13: The Department of Surgical Oncology at All India Institute of Medical Sciences (AIIMS) Jammu has successfully performed a highly complex surgery on a patient with a large left adrenal ...

Anxiety disorders are common. However, anxiety can also be a symptom of a general medical disorder or a side effect of a medication. Those cases must be identified promptly.

Learn more about whether Crinetics Pharmaceuticals, Inc. or Prestige Consumer Healthcare Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Operationally Seamless Phase 2/3 Study of Atumelnant for the Treatment of ACTH-Dependent ...

Based on the NCCN 1.2026 guidelines for the management of CSI seminoma, surveillance is strongly preferred for pT1-pT3 tumors, and the NCCN does not recommend risk-adapted treatment for CSI seminoma ...

(UroToday.com) The 2026 GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Laurence Albiges discussing REJOICE-PanTumor01, a phase 2 signal-seeking ...

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 13 hot stocks to buy with the highest upside potential. On January 30, Stifel raised its price target on Crinetics Pharmaceuticals Inc.